Recommended Immunization Schedule for Ages 0 to 18 Years

FDA update on H1N1 vaccine safety monitoring

January 19, 2010

The Commissioner of Food and Drugs has issued a letter to update healthcare professionals on the FDA/CDC experience with the H1N1 vaccination program and to provide some detail on the current vaccine safety monitoring program.

Fluzone High-Dose influenza vaccine approved for adults ages 65 and older

December 28, 2009

Fluzone High-Dose (inactivated influenza virus vaccine, from Sanofi Pasteur) has been approved for use in adults ages 65 years and older to prevent disease caused by influenza virus subtypes A and B.

Non-safety related recall of Sanofi Pasteur's H1N1 Pediatric vaccine

December 16, 2009

Sanofi Pasteur has issued a voluntary non-safety related recall of approximately 800,000 doses of its pediatric H1N1 vaccine in pre-filled syringes.

Phase 2 study of ADXS11-001 for advanced cervical cancer

December 15, 2009

Advaxis announced that it will collaborate with the Gynecologic Oncology Group (GOG) in a Phase 2, multicenter clinical trial of ADXS11-011 for the treatment of advanced cervical cancer in women who have failed prior cytotoxic therapy.

Phase 1 study of Advax AIDS vaccine delivery by electroporation

November 30, 2009

Ichor Medical Systems announced positive results from a Phase 1 study utilizing TriGrid electroporation technology in the delivery of Advax, a DNA-based AIDS vaccine candidate being developed by the Aaron Diamond AIDS Research Center.

AFLURIA

Immune System > Immunization

Trivalent, inactivated, "split virus" influenza vaccine (Types A and B); formulation changes annually; susp for IM inj; may contain trace amounts of neomycin sulfate, polymyxin B.

Updated: 1/11/2010

DECAVAC

Immune System > Immunization

Tetanus and diphtheria toxoids; aluminum adsorbed; susp for IM inj; contains thimerosal (trace).

ENGERIX-B PEDIATRIC/ADOLESCENT

Immune System > Immunization

Hepatitis B vaccine (recombinant) 10micrograms/0.5mL; aluminum hydroxide adsorbed; IM inj; preservative-free; contains thimerosal (trace).

HIBTITER

Immune System > Immunization

Haemophilus b conjugate vaccine (diphtheria CRM₁₉₇ conjugate) 10micrograms capsular oligosaccharides, 25micrograms diphtheria CRM₁₉₇ protein; per 0.5mL dose; IM inj; multidose vials contain thimerosal.

MENOMUNE-A/C/Y/W-135

Immune System > Immunization

Neisseria meningitidis polysaccharides 50micrograms; each of Group A, C, Y, and W-135 per 0.5mL; pwd for SC inj after reconstitution.

Immune System > Immunization

Contact the American Academy of Pediatrics, Centers for Disease Control and local health authorities for information on current immunization recommendations ...
more »

CerefolinNAC^® (L-methylfolate [Metafolin], methylcobalamin, N-acetylcysteine) Caplets: A Novel Approach to Early Memory Loss

January 27, 2010

New Product: Zenpep™ (pancrelipase) Delayed-Release Capsules

January 13, 2010

INVEGA^® SUSTENNA™ (paliperidone palmitate) Extended-Release Injectable Suspension for Acute and Maintenance Treatment of Schizophrenia

January 05, 2010

FORTEO^® (teriparatide [rDNA origin] injection) for Use in Glucocorticoid-Induced Osteoporosis

December 17, 2009

Important Clinical Information for MUCINEX^® D (guaifenesin and pseudoephedrine HCl extended-release bi-layer tablets)

November 19, 2009

Catch-Up Immunization Schedule for Children

February 02, 2010

A catch-up immunization schedule for children 4 months to 18 years of age. The tables show minimum intervals between doses for children who have delayed immunizations.

Guidelines for Vaccinating Pregnant Women

October 20, 2009

Routine and travel vaccines used to vaccinate pregnant women. List of vaccines that should be considered, special recommendations, and contraindications in pregnancy.

Recommended Adult Immunization Schedule

March 04, 2009

This schedule indicates the recommended age groups and medical indications for routine administration of currently licensed vaccines for persons 19 years and older.

Antiemetic Medications

February 05, 2010

A list of drugs used for the treatment of nausea. The chart includes the formulations, strengths, and usual doses for each antiemetic drug product.

Recommended Immunization Schedule for Ages 0 to 18 Years

January 21, 2010

This schedule indicates the recommended ages for routine administration of currently licensed childhood vaccines for children through age 18 years.